ACADIA PHARMACEUTICALS INC
Company Stats
- Market Cap
- $3.5B
- as of Sep 30, 2026
- Shares Outstanding
- 172.3M
- Free Float
- 39.2%
Income Statement
- Revenue
- $1.1B
- Operating Income
- $104.8M
- Net Income
- $391.0M
- EBITDA
- $105.7M
- Revenue Growth, 3Y
- 27.5%
- FCF Margin, 3Y Avg
- 9.5%
- FCF Margin, Worst Year
- 2.3%
Cash Flow
- Free Cash Flow
- $105.1M
- FCF Yield
- 3.0%
- Owner FCF Yield
- 1.5%
Balance Sheet
- Cash & Equivalents
- $177.7M
Returns & Capital
- SBC, 3Y Avg
- $61.9M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.1B | $105.1M | 9.8% |
| FY2024 | $957.8M | $157.2M | 16.4% |
| FY2023 | $726.4M | $16.7M | 2.3% |
| FY2022 | $517.2M | -$114.0M | -22.0% |
| FY2021 | $484.1M | -$126.8M | -26.2% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 9, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back